Connect Biopharma Holdings Ltd
NASDAQ:CNTB
Income Statement
Earnings Waterfall
Connect Biopharma Holdings Ltd
Income Statement
Connect Biopharma Holdings Ltd
| Dec-2024 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|
| Revenue | ||||
| Revenue |
26
N/A
|
26
+0%
|
26
+0%
|
|
| Operating Income | ||||
| Operating Expenses |
(46)
|
(62)
|
(80)
|
|
| Selling, General & Administrative |
(18)
|
(23)
|
(29)
|
|
| Research & Development |
(28)
|
(37)
|
(48)
|
|
| Operating Income |
(20)
N/A
|
(36)
-75%
|
(54)
-49%
|
|
| Pre-Tax Income | ||||
| Interest Income Expense |
4
|
5
|
6
|
|
| Non-Reccuring Items |
(2)
|
0
|
0
|
|
| Total Other Income |
3
|
3
|
3
|
|
| Pre-Tax Income |
(15)
N/A
|
(28)
-83%
|
(45)
-61%
|
|
| Net Income | ||||
| Tax Provision |
(0)
|
(0)
|
(0)
|
|
| Income from Continuing Operations |
(16)
|
(29)
|
(46)
|
|
| Net Income (Common) |
(16)
N/A
|
(29)
-83%
|
(46)
-60%
|
|
| EPS (Diluted) |
-0.28
N/A
|
-0.52
-86%
|
-0.82
-58%
|
|